Appointment: 2014 to 2017
Michael Garratt is a biologist interested in the physiological causes for aging, and how this process can be delayed through drug treatments and the manipulation of gene expression. He is particularly interested in sex-differences in aging and lifespan extension. Males and females usually have different lifespans and can show sex-specific responses to lifespan-extending interventions. Using the mouse as a model, Michael’s current research tests whether hormonal and metabolic differences between males and females generate sex-specific aging.
In addition to experimental work, Michael is modelling how aging interventions and breakthroughs in health research might impact human populations. He is exploring how human demography could change with the development of drugs that slow aging, and how this could impact longevity-linked insurance products and securities.